Search
Oral Presentation
Trifluridine/Tipiracil in combination with Capecitabine and Bevacizumab as upfront treatment for metastatic colorectal cancer: first results of the phase II TriComB study by GONO
Veronica Conca, Roberto Moretto, Francesca Bergamo, et al.
Oral Presentation
Activity of zipalertinib against active central nervous system (CNS) metastases in patients with non-small cell lung cancer (NSCLC) harboring EGFR exon 20 insertion (ex20ins)/other uncommon mutations
Helena A. Yu, Kadoaki Ohashi, Ryo Ariyasu, et al.
Poster Presentation
Treatment pathways and efficacy outcomes of patients with metastatic colorectal cancer (mCRC): a real-world prospective, longitudinal, cohort study (PROMETCO)
Yannay Miroshnik, Jean-Baptiste Bachet, Melena Marfi, et al.
Poster Presentation
Translational preclinical evaluation of zipalertinib in an amivantamab-resistant EGFR exon 20 insertion NSCLC model
Kohei Hayashi, Kota Hamamoto, Yoshimi Aoyagi, et al.
Poster Presentation
Phase I/II study of the pan-FGFR inhibitor futibatinib in children, adolescents and young adults with advanced tumors and FGFR alterations
Pablo Berlanga, Amaury Leruste, Eleni Karamouza, et al.